Management of Shoulder Osteoarthritis

First-Line Pharmacologic Treatment

The American Geriatrics Society recommends starting with acetaminophen as the first-line pharmacologic treatment for shoulder osteoarthritis pain, using regular dosing up to 4000 mg daily, as it provides effective pain relief with the best safety profile 1, 2
Acetaminophen should be the preferred initial medication for mild to moderate shoulder OA pain, with regular dosing potentially needed throughout the day 3, 4
The maximum daily dose is 4000 mg (4 grams), though some guidelines suggest staying at or below 3000 mg daily in elderly patients for enhanced safety 1, 5

If acetaminophen provides insufficient relief, consider topical NSAIDs (such as diclofenac gel) before oral NSAIDs, as they have minimal systemic absorption and lower risk of adverse effects 3, 5
Topical capsaicin is an alternative topical agent that may provide localized pain relief 3, 4
When topical treatments are inadequate, add or substitute with oral NSAIDs or COX-2 inhibitors at the lowest effective dose for the shortest possible duration 3, 4
Always prescribe a proton pump inhibitor alongside oral NSAIDs or COX-2 inhibitors for gastroprotection, choosing the one with lowest cost 3, 4

Carefully assess cardiovascular, gastrointestinal, and renal risk factors before prescribing any oral NSAID, particularly in patients over 50 years 5, 6
Elderly patients face substantially higher risks of GI bleeding, renal insufficiency, platelet dysfunction, and cardiovascular complications with NSAIDs 1, 2
NSAIDs should never be used in high doses or for prolonged periods, especially in older adults 1, 2
Take detailed medication histories including over-the-counter medications, as NSAIDs have considerable risk of drug-drug and drug-disease interactions (heart failure, hypertension, hepatic/renal disease) 1, 2

Consider intra-articular corticosteroid injections (such as triamcinolone hexacetonide) for moderate-to-severe shoulder pain, especially with evidence of inflammation or joint effusion 1, 3
Opioids may be considered only when acetaminophen, topical agents, and NSAIDs have failed or are contraindicated 3, 4
Use opioids cautiously given their side effect profile and addiction potential 3

Exercise and physical activity focusing on local muscle strengthening and general aerobic fitness 1, 3
Weight loss interventions if the patient is overweight or obese 3, 6
Patient education to counter misconceptions that OA is inevitably progressive 3, 6
Local heat or cold applications for temporary symptom relief 3, 6
Assistive devices and appropriate footwear with shock-absorbing properties 3, 6

Never exceed 4000 mg daily of acetaminophen, and consider lower limits (3000 mg) in elderly patients 1, 5
Never prescribe oral NSAIDs without gastroprotection (proton pump inhibitor) 3, 5
Avoid prolonged NSAID use at high doses, particularly in elderly patients who are at highest risk for serious adverse events 1, 2
Do not use glucosamine or chondroitin products, as current evidence does not support their efficacy 3, 4
Never overlook non-pharmacologic treatments—they are not optional adjuncts but essential core therapy 1, 3

Acetaminophen is the safest and most appropriate initial medication for an 84‑year‑old patient with coronary artery disease, because oral NSAIDs are contraindicated by cardiovascular comorbidity. (American Geriatrics Society) Strong recommendation 7

Intra‑articular corticosteroid injection (e.g., triamcinolone hexacetonide) provides short‑term pain relief lasting 2–4 weeks and is especially beneficial when baseline pain is severe. (Nature Reviews Rheumatology) Moderate recommendation 8

A structured land‑based exercise program—including quadriceps strengthening, aerobic conditioning, resistance training, and balance exercises—should be implemented for all patients. (Nature Reviews Rheumatology) Strong recommendation 8
Weight reduction in overweight or obese patients directly lowers mechanical stress on affected joints and improves symptoms. (Nature Reviews Rheumatology) Strong recommendation 8
Non‑pharmacologic therapies are considered core treatment and must not be omitted, regardless of pharmacologic choices. (Nature Reviews Rheumatology) Strong recommendation 8

The 2019 OARSI (Osteoarthritis Research Society International) guidelines explicitly advise against the use of any oral NSAIDs in patients with increased cardiovascular risk. Strong recommendation 8
In an 84‑year‑old with established coronary artery disease, NSAID use is associated with markedly higher risks of cardiovascular events, gastrointestinal bleeding, renal insufficiency, and platelet dysfunction. (American Geriatrics Society; Nature Reviews Rheumatology) Strong recommendation [7][8]
The ESCEO (European Society for Clinical and Economic Outcomes of Osteoporosis and Osteoarthritis) guidelines limit the duration of COX‑2 selective inhibitor therapy to a maximum of 30 days in high‑risk cardiovascular patients. Conditional recommendation 8
Age ≥ 65 years is an independent risk factor for cardiovascular, cerebrovascular, and gastrointestinal adverse outcomes from NSAIDs; guidelines therefore recommend avoiding oral NSAIDs in this age group. (Nature Reviews Rheumatology) Strong recommendation 8

All bullet points are derived from cited guideline or evidence sources and reflect the strength of recommendation when indicated.